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Klebsiella pneumoniae, especially hypervirulent strains, is an important member of Enterobac-
teriaceae family and contributes to different types 
of infection, including respiratory tract infections, 
urinary tract infections (UTI), blood stream (BSI) 
and wound infections [1]. Hypervirulent K. pneu-
moniae isolates, due to increased secretion of ex-
tracellular polysaccharide and toxins such as sal-
mochelin, yersiniabactin and aerobactin, as well 
as cell-cycle modulating non-ribosomal peptide 
Antibiotic resistance patterns  
and prevalence of class I,  
II and III Integrons among clinical 
isolates of Klebsiella pneumoniae
Abasali Delarampour1, Zahra Rashki Ghalehnoo2, Farzad Khademi3, Hamid Vaez2
1Microbiology Department, School of Medicine, Zahedan University of Medical Sciences, Iran; 
2Microbiology Department, School of Medicine, Zabol University of Medical Sciences, Iran; 
3Microbiology Department, School of Medicine, Ardabil University of Medical Sciences, Iran 
colibactin and pore-forming proteins, are in asso-
ciation with poor patients’ outcomes [2].
The ability of bacteria to capture and disseminate 
antibiotic resistance determinants by horizontal 
gene transfer are considered as a successful mech-
anism in development of multi-drug resistant 
(MDR) strains, especially among members of En-
terobacteriaceae family. Plasmids, transposons and 
integrons are mobile genetic elements that harbor 
antibiotic resistance genes and can be transferred 
via horizontal gene transfer mechanism [3].
Integrons  are recognized as genetic elements 
that acquire exogenous genes in the form of mo-
bile gene cassettes and play a pivotal important 
role in capturing and expressing diverse antimi-
crobial resistance genes. All integrons consist of 
three segments including intI, known as inte-
Klebsiella pneumoniae is a well-known pathogen and 
contributes to different types of infection. To investi-
gate the antibiotic resistance profiles and prevalence of 
class I, II, and III integrons among clinical isolates of K. 
pneumoniae, a total of 142 non-duplicate clinical isolates 
were collected. Antibiotic susceptibility was assessed 
using Kirby-Bauer’s disk diffusion method and Clin-
ical and Laboratory Standards Institute (CLSI) guide-
lines. Polymerase chain reaction (PCR) method was 
used to identify class I, II and III integrons. The isolates 
were mostly resistant against streptomycin (62 strains, 
43.7%) and ceftriaxone (42 strains, 29.6%). Twenty-six 
(18.3%) isolates were found to be multi-drug resist-
SUMMARY
ant (MDR). Class I and II integrons were detected in 
65 isolates (45.8%) and 1 (0.7%) isolate, respectively. 
The findings of this study revealed that the prevalence 
of streptomycin-resistant isolates is high, and its use 
must be restricted. Also, our results revealed that class 
I integrons are widely prevalent in clinical isolates of K. 
pneumoniae and a significant association was observed 
between resistance against imipenem, ciprofloxacin, 
gentamicin and streptomycin and the presence of in-
tegrons, necessitating appropriate infection control 
programs. 
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gron-integrase gene encoding a tyrosine recombi-
nase enzyme, promoter site (Pc) and recombina-
tion site (attI), where integrase inserts new cap-
tured resistance gene [4].
Based on differences in sequence of integrase 
genes five classes of integrons including class I, 
II, III, IV and V have been reported. However, the 
last two classes including integrons class IV and V 
have not been identified in K. pneumoniae [3].
Class I integron is the most frequently report-
ed integron among Enterobacteriaceae, especially 
Klebsiella spp. Class I integron platforms are com-
posed of two conserved regions called 3’CS and 
5’CS with internal variable region encoding a va-
riety of antimicrobial resistance genes including 
aminoglycosideadenyl transferase (aadA), and 
the  dihydrofolatereductase  (dfrA), conferring re-
sistance against streptomycin/spectinomycin 
and trimethoprim, respectively [5]. Also, different 
studies have reported that class II and III inte-
grons are barely being isolated from K. pneumo-
niae, harboring different resistance genes and are 
responsible for resistance against a wide variety 
of antibiotics such as beta-lactam, aminoglycoside 
and trimethoprim, as well as erythromycin [3-5].
Owing to the great impact of integron-positive 
isolates on resistance to antibiotic and patients’ 
outcomes, the aim of this study was to investigate 
the antibiotic resistance profiles and prevalence of 
class I, II, and III integrons among clinical isolates 
of K. pneumoniae. 
n MATERIALS AND METHODS
Sample collection and identification
A total of 142 non-duplicate, consecutive clinical 
isolates of K. pneumoniae were collected from pa-
tients referred to Sistan and Balouchestan hospi-
tals during March 2018 and March 2019. Standard 
conventional tests and species-specific PCR were 
used to identify K. pneumoniae [6]. The study was 
approved by ethical committee of Zabol Universi-
ty of Medical Sciences (IR.ZBMU.REC.1397.179).
Antimicrobial susceptibility testing
Antibiotic susceptibility was assessed using Kir-
by-Bauer’s disk diffusion method and Clinical 
and Laboratory Standards Institute guidelines [7]. 
Used antibiotics (MSAT, Merseyside, UK) were 
as follows: ciprofloxacin (CIP, 5 µg), meropenem 
(MEM, 10 µg), imipenem (IMP, 10 µg), amikacin 
(AMK, 30 µg), ertapenem (ETP, 10 µg), cefoxitin 
(FOX, 30 µg), cefepime (CPM, 30 µg), strepto-
mycin (S, 10 µg), ceftriaxone (CRO, 30 µg) and 
gentamicin (GM, 10 µg). Pseudomonas aeruginosa 
ATCC 27853 were used as the quality control.
Molecular detection of Integrons by polymerase chain 
reaction (PCR)
The isolates were cultured (24h) on MacConkey 
agar at 37°C. Then, genomic DNAs were extract-
ed by boiling method according to previous in-
structions [8]. Oligonucleotide primers used in 
this study are shown in Table 1. All PCR reactions 
were performed using Ampliqon (Denmark) 
ready to use master mix. For each integron, PCR 
reaction mixtures in final volume of 20 µL, com-
prised 15 µL ready to use master mix, 3 µL ex-
tracted DNA and 1 µL forward primer (100 pmol) 
and 1 µL reverse primer (100 pmol) were used [9]. 
PCR program was applied as follows: initial de-
naturation at 94°C for 6 min, 35 cycles of denatur-
ation at 94°C for 45 sec, annealing at 55°C for 45 
sec, extension at 72°C for 1 min and a final exten-
sion at 72°C for 10 min. Finally, The PCR products 
were separated using agarose gel electrophoresis 
(1%) and visualized after staining with Sybr safe 
(Thermo Fisher Scientific Inc.).
Table 1 - Oligonucleotide primers used in this study.
Primer Nucleotide sequence (5’….3’) PCR target Expected size (bp) Reference
Inti1F CCT CCC GCA CGA TGA TC intI1 280 9
Inti1R TCC ACG CAT CGT CAG GC
Inti2F TTA TTG CTG GGA TTA GGC intI2 233 9
Inti2R ACG GCT ACC CTC TGT TAT C
Inti3F AGT GGG TGG CGA ATG AGT G intI3 600 9
Inti3R TGT TCT TGT ATC GGC AGG TG
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Statistical analysis
Statistical analysis of results was carried out with 
SPSS software (SPSS Chicago, IL). The Chi-square 
test and Fisher’s exact test were used for statisti-
cal analysis. A P value <0.05 was considered sta-
tistically significance.
n RESULTS
Distribution of sources of collected samples was 
as follows: urine 69 (48.6%), sputum 53 (37.3%), 
blood 8 (5.6%), wound 5 (3.5%) and other clinical 
specimens (synovial fluid, abscess and eye dis-
charge) 7 (4.9%). From these, fifty-seven samples 
(40.1%) were taken from female and 85 (59.9%) 
from male patients. Also, out of 142 isolated 
bacteria, 51 (35.9%) were from outpatients and 
91 (64.1%) were from hospitalized patients. The 
isolates were mostly resistant to streptomycin (62 
strains, 43.7 %) and ceftriaxone (42 strains, 29.6%), 
followed by ciprofloxacin (39 strains, 27.5%) and 
cefepime (37 strains, 26.1%) (Table 2). Twenty-six 
(18.3%) isolates were found to be MDR, showing at 
least resistance against three antibiotics of differ-
ent classes such as aminoglycoside, beta-lactams 
and quinolones. Class I and II integrons were de-
tected in 65 (45.8%) and 1 (0.7%) isolates, respec-
tively. Also, one isolate had class I and II integron, 
Table 2 - Antibiotic resistance profiles of isolated K. pneumoniae.
Antibiotic Susceptible (n, %) Intermediate (n, %) Resistant (n, %)
Meropenem 127 (89.4) 2 (1.4) 13 (9.2)
Imipenem 127 (89.4) 2 (1.4) 13 (9.2)
Ertapenem 127 (89.4) 2 (1.4) 13 (9.2)
Streptomycin 74 (52.1) 6 (4.2) 62 (43.7)
Amikacin 121 (85.2) 3 (2.1) 18 (12.7)
Gentamicin 98 (69) 0 (0) 44 (31)
Cefoxitin 114 (80.3) 1 (0.7) 27 (19)
Cefepime 102 (71.8) 3 (2.1) 37 (26.1)
Ceftriaxone 97 (63.8) 3 (2.1) 42 (29.6)
Ciprofloxacin 85 (59.9) 18 (12.7) 39 (27.5)
Table 3 - Association between antibiotic resistance and integron carriage in clinical isolates of K. pneumoniae.
Antibiotic Integron-positive
isolates (n = 65)
Integron-negative




S (%) I (%) R (%) S (%) I (%) R (%) S (%) I (%) R (%)
Meropenem 50 (76.9) 2 (3.1) 13 (20) 77 (100) 0 (0) 0 (0) 127 (89.4) 2 (1.4) 13 (9.2) 0.000
Imipenem 50 (76.9) 2 (3.1) 13 (20) 77 (100) 0 (0) 0 (0) 127 (89.4) 2 (1.4) 13 (9.2) 0.000
Ertapenem 50 (76.9) 2 (3.1) 13 (20) 77 (100) 0 (0) 0 (0) 127 (89.4) 2 (1.4) 13 (9.2) 0.000
Streptomycin 18 (27.7) 5 (7.7) 42 (64.6) 56 (72.7) 1 (1.3) 20 (26) 74 (52.1) 6 (4.2) 62 (43.7) 0.000
Amikacin 49 (75.4) 1 (1.5) 15 (23.1) 72 (93.5) 2 (2.6) 3 (3.9) 121 (85.2) 3 (2.1) 18 (12.7) 0.003
Gentamicin 32 (49.2) 0 (0) 33 (50.8) 66 (85.7) 0 (0) 11 (14.3) 98 (69) 0 (0) 44 (31) 0.000
Cefoxitin 44(67.7) 0 (0) 21 (32.3) 70 (90.9) 1 (1.3) 6 (7.8) 114 (80.3) 1 (0.7) 27 (19) 0.001
Cefepime 36 (55.4) 0 (0) 29 (44.6) 66 (85.7) 3 (3.9) 8 (10.4) 102 (71.8) 3 (2.1) 37 (26.1) 0.000
Ceftriaxone 36 (55.4) 0 (0) 29 (44.6) 61 (72.9) 3 (3.9) 13 (16.9) 97 (63.8) 3 (2.1) 42 (29.6) 0.001
Ciprofloxacin 23 (35.4) 10 (15.4) 32 (49.2) 62 (80.5) 8 (10.4) 7 (9.1) 85 (59.9) 18 (12.7) 39 (27.5) 0.000
S, susceptible; I, intermediate; R, resistant. Significant values are in bold.
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simultaneously. Class III integron was not found. 
As shown in Table 3, the association between 
integron carriage and antibiotic resistance was 
most significant for cefepime, meropenem, imi-
penem, ciprofloxacin, gentamicin and streptomy-
cin (P≤0.001). Moreover, the comparison of MDR 
phenotype in the integron-positive and -negative 
isolates revealed that integron-positive isolates 
had much higher rate of MDR (88.5%) compared 
with integron-negative (11.5%) isolates (P<0.001).
n DISCUSSION
Infections caused by K. pneumoniae strains pose 
serious threat to human health worldwide owing 
to the great ability of this microorganism to pro-
duce different virulence factors and to develop 
antibiotic resistance. Therefore, we investigated 
the antibiotic resistance patterns and prevalence 
of class I, II and III integrons among clinical iso-
lates of K. pneumoniae. In this study, K. pneumoni-
ae showed varying levels of resistance against the 
tested antibiotics revealing that carbapenems are 
the most effective antibiotics against K. pneumoni-
ae, with 89.4% of all isolates being susceptible. A 
comprehensive meta-analysis study conducted in 
Iran showed that the prevalence of carbapenem 
resistant K. pneumoniae (CR K. pneumoniae) was 
about 11%, ranging from less than 1% to 58% [10]. 
Our findings on the prevalence of CR K. pneu-
moniae were higher than that of some European 
countries such as Estonia (0%), Sweden (0%), Fin-
land (0%), Germany (0.1%), Norway (0.1%) and 
Netherlands (0.1%), whereas the prevalence of CR 
K. pneumoniae in Italy and Greece was reported to 
be higher than that of our results, with 33.5% and 
61.5% resistance rate, respectively [11]. 
These contradictory findings may be related to 
the widespread use of antibiotics, variable sample 
sizes, poor infection control policies, differences 
in geographical locations and the presence of 
some risk factors such as previous hospitalization 
and long-term staying at ICU [12, 13].
The findings revealed that isolates were mostly 
resistant against streptomycin, gentamicin and 
ceftriaxone, with 43%, 31% and 29% of isolates 
being resistant, respectively. The prevalence of 
antimicrobial resistance isolates is not same in 
different regions of Iran. For instance, Ranjbar et 
al, in their study which was conducted in Isfahan 
province, reported that 53%, 60%, and 80% of the 
investigated K. pneumoniae isolates were resist-
ant to gentamicin, amikacin and ciprofloxacin, 
respectively [14]. Moreover, it has been reported 
that the percentage of resistance to different anti-
biotics in different provinces of Iran is much high-
er than that of most European countries. For ex-
ample, resistance to gentamicin varied from 6.2% 
in Rasht province to 69.8% in Tabriz province. 
Also, resistance to other antibiotics such as cipro-
floxacin varied from 20% in Zahedan province to 
53.2% in Isfahan province [10].
Different antibiotic resistance rates probably re-
sulted from indiscriminate use of antibiotics. 
Also, it has been reported that previous hospitali-
zation at ICU, presence of central line device and 
exposure to antibiotics are associated with higher 
rates of antibiotic resistance [8, 10].
Several different mechanisms have been identi-
fied that can confer resistance to different antibi-
otics belonging to different classes. The produc-
tion of extended-spectrum beta-lactamase (ES-
BL)-enzymes, efflux pump overexpression, target 
modifying enzymes and mutation are the most 
important mechanisms that have been identified 
in K. pneumoniae [15].
In the next step of this study, the prevalence of class 
I (intl1), class II (intl2) and class III (intl3) integrons 
were investigated. PCR results showed that 45.8% 
(n=65) and 0.7% (n=1) of isolates had  intl1  and 
intl2 genes, respectively; but intl3 was not found 
in the studied isolates.
The findings of different studies demonstrated 
that the intl1 is the most predominant integrons 
among K. pneumoniae strains. For instance, Li et 
al., in a study conducted in China, reported that 
51.1% (90/176) of investigated K. pneumoniae had 
intl1 genes [16]. Likewise, two independent stud-
ies conducted in Yazd province and Kashan prov-
ince (Iran), reported that the prevalence of intl1 
was 91% and 100%, respectively [17, 18].
The spread of integron-positive isolates in hospi-
tal may lead to the dissemination of multi-drug 
resistant isolates, because these mobile genetic 
elements often contain multiple drug resistance 
genes that can be disseminated among bacteria 
through horizontal gene transfer [19, 20].
Also, our findings showed significant association 
between intl1 and resistance to cefepime, mero-
penem, imipenem, ciprofloxacin, gentamicin and 
streptomycin (P≤0.001). It has been reported that 
there is a significant relationship between inte-
68 A. Delarampour, Z. Rashki Ghalehnoo, F. Khademi, et al.
grons and resistance to antibiotics. A study con-
ducted by Xu et al., reported results similar to 
ours revealing that the prevalence of resistance 
against different antibiotics including gentamicin, 
amikacin, streptomycin and ciprofloxacin in intl1 
positive isolates was significantly higher than that 
of integron negative isolates [19]. 
It is well documented that class I integrons play a 
significant role in the dissemination of antibiotic 
resistance in clinical bacterial isolates. In fact, the 
great ability of integrons in capturing multiple 
drug resistance genes has led to the emergence of 
class I integrons with different gene cassette ar-
rays, encoding different resistance genes which 
may confer resistance against different drugs [20].
n CONCLUSIONS
In order to impede the emergence of infections 
caused by antibiotic resistance bacteria and 
launch appropriate infection control policies, con-
stant monitoring of antibiotic resistance profiles 
is of pivotal importance. Based on the results of 
this study, the prevalence of resistance to imipe-
nem, meropenem and ertapenem was not at high 
level, however, resistance to streptomycin was 
high. Integrons appear to comprise one of the 
common features among K. pneumoniae isolates 
in our region, especially among MDR strains, and 
are associated with a high prevalence of antibiotic 
resistance. Accurate and rapid detection of inte-
gron harboring isolates is completely necessary, 
because other drug resistance genes are often lo-
cated at these mobile genetic elements and may 
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